BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 11753073)

  • 21. Immunomodulatory properties of defensins and cathelicidins.
    Bowdish DM; Davidson DJ; Hancock RE
    Curr Top Microbiol Immunol; 2006; 306():27-66. PubMed ID: 16909917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human antimicrobial peptides: defensins, cathelicidins and histatins.
    De Smet K; Contreras R
    Biotechnol Lett; 2005 Sep; 27(18):1337-47. PubMed ID: 16215847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel cathelicidins in horse leukocytes(1).
    Scocchi M; Bontempo D; Boscolo S; Tomasinsig L; Giulotto E; Zanetti M
    FEBS Lett; 1999 Sep; 457(3):459-64. PubMed ID: 10471829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
    Zaiou M; Nizet V; Gallo RL
    J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2010 Sep; 31(9):1791-8. PubMed ID: 20600427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.
    Nagaoka I; Tamura H; Hirata M
    J Immunol; 2006 Mar; 176(5):3044-52. PubMed ID: 16493063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human cathelicidin LL-37 is a chemoattractant for eosinophils and neutrophils that acts via formyl-peptide receptors.
    Tjabringa GS; Ninaber DK; Drijfhout JW; Rabe KF; Hiemstra PS
    Int Arch Allergy Immunol; 2006; 140(2):103-12. PubMed ID: 16557028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.
    Turner J; Cho Y; Dinh NN; Waring AJ; Lehrer RI
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2206-14. PubMed ID: 9736536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of cathelicidins in the innate host defenses of mammals.
    Zanetti M
    Curr Issues Mol Biol; 2005 Jul; 7(2):179-96. PubMed ID: 16053249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules.
    Cowland JB; Johnsen AH; Borregaard N
    FEBS Lett; 1995 Jul; 368(1):173-6. PubMed ID: 7615076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection.
    Lee PH; Ohtake T; Zaiou M; Murakami M; Rudisill JA; Lin KH; Gallo RL
    Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3750-5. PubMed ID: 15728389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and activity of a novel cathelicidin from domestic cats.
    Leonard BC; Chu H; Johns JL; Gallo RL; Moore PF; Marks SL; Bevins CL
    PLoS One; 2011 Apr; 6(4):e18756. PubMed ID: 21533281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Did cathelicidins, a family of multifunctional host-defense peptides, arise from a cysteine protease inhibitor?
    Zhu S
    Trends Microbiol; 2008 Aug; 16(8):353-60. PubMed ID: 18632274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.
    Cobo ER; Kissoon-Singh V; Moreau F; Holani R; Chadee K
    Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina.
    Sørensen OE; Gram L; Johnsen AH; Andersson E; Bangsbøll S; Tjabringa GS; Hiemstra PS; Malm J; Egesten A; Borregaard N
    J Biol Chem; 2003 Aug; 278(31):28540-6. PubMed ID: 12759353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils.
    Sørensen O; Arnljots K; Cowland JB; Bainton DF; Borregaard N
    Blood; 1997 Oct; 90(7):2796-803. PubMed ID: 9326247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.
    von Haussen J; Koczulla R; Shaykhiev R; Herr C; Pinkenburg O; Reimer D; Wiewrodt R; Biesterfeld S; Aigner A; Czubayko F; Bals R
    Lung Cancer; 2008 Jan; 59(1):12-23. PubMed ID: 17764778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cathelicidins--structure, function and evolution.
    Tomasinsig L; Zanetti M
    Curr Protein Pept Sci; 2005 Feb; 6(1):23-34. PubMed ID: 15638766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity.
    Fabisiak A; Murawska N; Fichna J
    Pharmacol Rep; 2016 Aug; 68(4):802-8. PubMed ID: 27117377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma.
    Sørensen O; Cowland JB; Askaa J; Borregaard N
    J Immunol Methods; 1997 Aug; 206(1-2):53-9. PubMed ID: 9328568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.